Inhibition of the different levels of the GHRH-GH-IGF axis apparently exerts a beneficial impact on the progress of Alzheimer's disease [7, 10, 11, 15, 17]. The gene discussed is GH1; the disease is early-onset autosomal dominant Alzheimer disease.